文献速递呼吸危重症与机械通气

极早产儿鼻塞CPAP不同后备模式SpO2达标时间随机交叉试验

Time spent within the SpO2 target range during nasal CPAP therapy with different backup modes in extremely preterm infants: a randomised cross-over trial
RSS 订阅 · BMJ Open Respiratory Research

本研究为单中心随机交叉试验,纳入24例极早产儿,比较鼻塞CPAP治疗中呼吸暂停时备用NIPPV在自主呼吸恢复后立即停止与逐步减停两种策略对SpO2达标时间的影响。结果显示两种策略的SpO2达标时间无差异,逐步减停组平均气道压显著升高、呼吸频率降低,但经皮二氧化碳分压和心率无差异。

要点

  • 极早产儿nCPAP备用NIPPV立即停止与逐步减停的SpO2达标时间无显著差异(61.1% vs 64.7%,p=0.15)。
  • 逐步减停组平均气道压显著高于立即停止组(7.2 vs 5.6 cm H2O,p<0.01),呼吸频率降低(60.1 vs 63.8,p=0.02)。
  • 两组在低氧和高氧时间、严重血氧下降次数及脑组织氧合参数上均无差异。

核心结论

  • 逐步减停备用NIPPV与立即停止相比,并未改善极早产儿SpO2达标时间。
  • 新技术模式需经严谨临床试验验证安全性和有效性后方可用于日常实践。

研究设计与样本

  • 单中心随机交叉试验,纳入24例极早产儿(中位胎龄24+1周,中位日龄43天)。
  • 受试儿在nCPAP治疗中呼吸暂停>4秒时使用备用NIPPV,随机分配至自主呼吸恢复后立即停止或逐步减停备用NIPPV。

主要发现

  • SpO2达标时间(88%–95%)两组无差异:立即停止组61.1% vs 逐步减停组64.7%,p=0.15。
  • 逐步减停组平均气道压显著升高(7.2 vs 5.6 cm H2O,p<0.01),呼吸频率降低(60.1 vs 63.8,p=0.02)。
  • 两组低氧和高氧时间、 prolonged(>30秒)及严重(<80%和<70%)血氧下降次数、脑组织氧合参数均无差异。
  • 两组平均吸入氧浓度、经皮二氧化碳分压和心率无差异。

临床怎么用

  • 对于极早产儿nCPAP治疗中呼吸暂停后备用NIPPV的管理,逐步减停策略未显示优于立即停止的临床获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objectives To study the efficacy of different modes of backup nasal intermittent positive pressure ventilation (NIPPV) during nasal continuous positive airway pressure (nCPAP) therapy to keep extremely preterm (EPT) infants within the oxygen saturation (SpO 2 ) target range. Design Single-centre randomised cross-over trial. Setting Level 3 neonatal intensive care unit. Participants 24 EPT infants (median gestational age of 24+1 and median postnatal age of 43 days). Interventions EPT infants on nCPAP therapy with backup NIPPV during apnoea >4 s were assigned in random sequence to immediate cessation of backup NIPPV or to stepwise reduction of backup NIPPV support on restart of spontaneous respiration. Main outcome measures Primary outcome was time spent within the SpO 2 target range (88%–95%). Secondary outcomes included frequency and duration of hypoxaemic and hyperoxaemic episodes, impact on cerebral tissue oxygenation, parameters of gas exchange and vital signs. Results The mean percentage of time spent within the SpO 2 target range did not differ between immediate cessation of backup NIPPV on restart of spontaneous respiration compared with the stepwise reduction of backup NIPPV (61.1% vs 64.7%, p=0.15). There were no differences in the time spent below or above the SpO 2 target range, the number of prolonged (>30 s) and severe (<80% and <70%) desaturations and in the parameters of cerebral tissue oxygenation. The stepwise reduction of backup NIPPV resulted in a significant increase in mean airway pressure (7.2 cm H 2 0 vs 5.6 cm H 2 0, p<0.01) and reduction in respiratory frequency (60.1 vs 63.8, p=0.02) compared with the immediate cessation of backup NIPPV on restart of spontaneous respiration, while mean fraction of inspired oxygen, transcutaneous carbon dioxide pressure and heart rate did not vary between the two interventions. Conclusion Our findings underpin that new sophisticated ventilation modes like stepwise reduction of backup NIPPV do not necessarily provide a clinical benefit compared with the standard mode. For this, technological advances require robust evaluation within well-designed clinical trials demonstrating the safety and efficacy before being used in everyday clinical practice. Trial registration German Clinical Trials Register; registration number: DRKS00031956 ( https://drks.de/search/en/trial/DRKS00031956 ), date of registration: 26 May 2023.

来源:BMJ Open Respiratory Research,查看原文。版权归原作者所有。

引用

  1. BMJ Open Respiratory Research:Time spent within the SpO2 target range during nasal CPAP therapy with different backup modes in extremely preterm infants: a randomised cross-over trial

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。